Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to compare clinical outcomes of patients considered to be high risk for prosthetic dislocation undergoing primary total hip arthroplasty (THA) with the use of a dual mobility bearing versus a conventional, single bearing design.


Clinical Trial Description

This study aims to compare the clinical outcomes of patients considered to be at high risk for prosthetic dislocation undergoing primary total hip arthroplasty (THA) with the use of a dual mobility bearing versus a conventional, single-bearing design. We hypothesize that in primary THA patients considered to be at high risk for prosthetic dislocation, the use of dual-mobility components will be associated with a lower dislocation rate in the first year following the index procedure. We do not anticipate a difference. In other clinical outcome measures or functional outcome scores between the two cohorts. Study Design: Randomized controlled trial with two groups: THA with dual mobility. 44 components vs THA with single-bearing designs ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04092634
Study type Interventional
Source Rush University Medical Center
Contact Denis Nam, MD, MSc
Phone (312)432-2468
Email denis.nam@rushortho.com
Status Recruiting
Phase Phase 4
Start date November 1, 2017
Completion date December 1, 2034

See also
  Status Clinical Trial Phase
Recruiting NCT04090359 - Dual Mobility Acetabular Cups in Revision TJA Phase 4
Enrolling by invitation NCT05587244 - G7 Freedom Constrained Vivacit-E Liners N/A
Enrolling by invitation NCT05548972 - G7 Dual Mobility With Vivacit-E or Longevity PMCF N/A
Not yet recruiting NCT04685239 - Dual Mobility Cup Versus Unipolar Cup N/A